Experimental Animal Models for Studying Lung Cancer



Lung cancer is the leading cause of cancer-related mortality for both men and women worldwide. The use of animal models of lung cancer is necessary to improve our understanding of lung tumor biology and facilitate novel therapies and diagnostics. To this end, animal models should mimic both the genetic alterations found in human lung tumors and their histological characteristics. Currently, several types of animal models are widely used for experimental lung cancer research. These include chemically induced lung tumors, transgenic mouse models, and human tumor xenografts. A single model system that faithfully recaptures the entire spectrum of lung cancer biology is unlikely to exist. Different models that accurately reflect the various aspects of the disease are necessary to properly investigate such a complex disease. Tumorigenesis, proliferation, invasion, angiogenesis, metastasis, prevention, and therapy are all areas where specific models are required to ensure proper experimental design.

The purpose of this chapter is to summarize the various lung cancer model systems in use today and define both their utility and limitations. We will briefly describe all of these models and provide a more detailed description of the orthotopic lung cancer xenograft models.


Lung Cancer Lung Tumor Human Lung Cancer Human Tumor Xenograft Orthotopic Model 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Liu J, Johnston MR (2002) Animal models for studying lung cancer and evaluating novel intervention strategies. Surg Oncol 11:217–27.PubMedCrossRefGoogle Scholar
  2. 2.
    Siemann DW (1984) Modification of chemotherapy by nitroimidazoles. Int J Radiat Oncol Biol Phys 10: 1585–94.PubMedCrossRefGoogle Scholar
  3. 3.
    Corbett TH, Roberts BJ, Leopold WR, Peckham JC, Wilkoff LJ, Griswold DP, Schabel FM (1984) Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. Cancer Res 44: 717–26.PubMedGoogle Scholar
  4. 4.
    Balmain A, Harris CC (2000) Carcinogenesis in mouse and human cells: parallels and paradoxes. Carcinogenesis 21: 371–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Malkinson AM (2001) Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung. Lung Cancer 32: 265–79.PubMedCrossRefGoogle Scholar
  6. 6.
    Curt GA (1994) The use of animal models in cancer drug discovery and development. Stem Cells 12: 23–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Tuveson DA, Jacks T (1999) Modeling human lung cancer in mice: similarities and shortcomings. Oncogene 18: 5318–24.PubMedCrossRefGoogle Scholar
  8. 8.
    Shimkin MB, Stoner GD (1975) Lung tumors in mice: application to carcinogenesis bioassay. Adv Cancer Res 21: 1–58.PubMedCrossRefGoogle Scholar
  9. 9.
    Stoner GD, Adam-Rodwell G, Morse MA (1993) Lung tumors in strain A mice: application for studies in cancer chemoprevention. J Cell Biochem Suppl. 17F: 95–103.CrossRefGoogle Scholar
  10. 10.
    Wattenberg LW, Leong JL (1970) Inhibition of the carcinogenic action of benzo(a)pyrene by flavones. Cancer Res 30: 1922–5.PubMedGoogle Scholar
  11. 11.
    Malkinson AM (1992) Primary lung tumors in mice: an experimentally manipulable model of human adenocarcinoma. Cancer Res 52: 2670s–6s.PubMedGoogle Scholar
  12. 12.
    Kim SH, Lee CS (1996) Induction of benign and malignant pulmonary tumors in mice with benzo(a)pyrene. Anticancer Res 16: 465–70.PubMedGoogle Scholar
  13. 13.
    Witschi H, Espiritu I, Dance ST, Miller MS (2002) A mouse lung tumor model of tobacco smoke carcinogenesis. Toxicol Sci 68: 322–30.PubMedCrossRefGoogle Scholar
  14. 14.
    Bogen KT et al. (2002) Lung tumors in A/J mice exposed to environmental tobacco smoke: estimated potency and implied human risk. Carcinogenesis 23: 511–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Rapp UR, Todaro GJ (1980) Generation of oncogenic mouse type C viruses: in vitro selection of carcinoma-inducing variants. Proc Natl Acad Sci USA 77: 624–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Malkinson AM (1989) The genetic basis of susceptibility to lung tumors in mice. Toxicology 54: 241–71.PubMedCrossRefGoogle Scholar
  17. 17.
    Miller MS, Jones AB, Chauhan DP et al. (1990) Role of the maternal environment in determining susceptibility to transplacentally induced chemical carcinogenesis in mouse fetuses. Carcinogenesis 11:1979–84PubMedGoogle Scholar
  18. 18.
    Rehm S, Lijinsky W, Singh G et al. (1991) Mouse bronchiolar cell carcinogenesis. Histologic characterization and expression of Clara cell antigen in lesions induced by N-nitrosobis-(2-chloroethyl) ureas. Am J Pathol 139:413–22PubMedGoogle Scholar
  19. 19.
    White MR, Grendon A, Jones HB (1970) Tumor incidence and cellularity in lungs of mice given various dose schedules of urethan. Cancer Res 30:1030–6.PubMedGoogle Scholar
  20. 20.
    Stoner GD, Greisiger EA, Schut HA (1984) A comparison of the lung adenoma response in strain A/J mice after intraperitoneal and oral administration of carcinogens. Toxicol Appl Pharmacol 72:313–23.PubMedGoogle Scholar
  21. 21.
    Anderson LM, Priest LJ (1980) Reduction in the transplacental carcinogenic effect of methylcholanthrene in mice by prior treatment with beta-naphthoflavone. Res Commun Chem Pathol Pharmacol 30: 431–46.PubMedGoogle Scholar
  22. 22.
    Wattenberg LW (1973) Inhibition of chemical carcinogen-induced pulmonary neoplasia by butylated hydroxyanisole. J Natl Cancer Inst 50: 1541–4.PubMedGoogle Scholar
  23. 23.
    Lesca P (1983) Protective effects of ellagic acid and other plant phenols on benzo[a]pyrene-induced neoplasia in mice. Carcinogenesis 4: 1651–3.PubMedCrossRefGoogle Scholar
  24. 24.
    Jackson EL, Willis N, Mercer K et al. (2001) Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15: 3243–48.PubMedCrossRefGoogle Scholar
  25. 25.
    Gunning WT, Kramer PM, Lubet RA, Steele VE, Pereira MA (2000) Chemoprevention of vinyl carbamate-induced lung tumors in strain A mice. Exp Lung Res 26: 757–72.PubMedCrossRefGoogle Scholar
  26. 26.
    Wang ZY, Hong JY, Huang MT, Reuhl KR, Conney AH, Yang CS (1992) Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res 52(7):1943–7.PubMedGoogle Scholar
  27. 27.
    Jalbert G, Castonguay A (1992) Effects of NSAIDs on NNK-induced pulmonary and gastric tumorigenesis in A/J mice. Cancer Lett 66: 21–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Duperron C, Castonguay A (1997) Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice. Carcinogenesis 18: 1001–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Moody TW, Leyton J, Zakowicz H et al. (2001) Indomethacin reduces lung adenoma number in A/J mice. Anticancer Res 21: 1749–55.PubMedGoogle Scholar
  30. 30.
    Kozaki K, Koshikawa K, Tatematsu Y et al. (2001) Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis. Oncogene 20: 4228–34.PubMedCrossRefGoogle Scholar
  31. 31.
    Kisley LR, Barrett BS, Dwyer-Nield LD, Bauer AK, Thompson DC, Malkinson AM (2002) Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice. Carcinogenesis 23: 1653–60.PubMedCrossRefGoogle Scholar
  32. 32.
    Keith RL, Miller YE, Hudish TM et al. (2004) Pulmonary Prostacyclin Synthase Overexpression Chemoprevents Tobacco Smoke Lung Carcinogenesis in Mice. Cancer Res 64: 5897–904.PubMedCrossRefGoogle Scholar
  33. 33.
    Hahn FF, Lundgren DL (1992) Pulmonary neoplasms in rats that inhaled cerium-144 dioxide. Toxicol Pathol 20: 169–78.PubMedCrossRefGoogle Scholar
  34. 34.
    Adams JM, Cory S (1991) Transgenic models of tumor development. Science 254: 1161–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Thomas H, Balkwill F (1995) Assessing new anti-tumour agents and strategies in oncogene transgenic mice. Cancer Metastasis Rev 14: 91–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Hogan B (1986) Manipulating the mouse embryo: a laboratory manual. In: Hanahan D (eds) Cold Spring Harbor Laboratory Manual. Cold Spring Harbor, New York.Google Scholar
  37. 37.
    Gordon JW, Ruddle FH (1983) Gene transfer into mouse embryos: production of transgenic mice by pronuclear injection. Methods Enzymol 101: 411–33.PubMedCrossRefGoogle Scholar
  38. 38.
    Jaenisch R (1980) Retroviruses and embryogenesis: microinjection of Moloney leukemia virus into midgestation mouse embryos. Cell 19: 181–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Soriano P, Jaenisch R (1986) Retroviruses as probes for mammalian development: allocation of cells to the somatic and germ cell lineages. Cell 46: 19–29.PubMedCrossRefGoogle Scholar
  40. 40.
    Dosaka-Akita H, Cagle PT, Hiroumi H et al. (2000) Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung. Cancer 88: 550–6.PubMedCrossRefGoogle Scholar
  41. 41.
    Ehrhardt A, Bartels T, Geick A, Klocke R, Paul D, Halter R (2001) Development of pulmonary bronchiolo-alveolar adenocarcinomas in transgenic mice overexpressing murine c-myc and epidermal growth factor in alveolar type II pneumocytes. Br J Cancer 84: 813–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Fijneman RJ, de Vries SS, Jansen RC, Demant P (1996) Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat Genet 14: 465–7.PubMedCrossRefGoogle Scholar
  43. 43.
    Fong KM, Sekido Y, Minna JD (1999) Molecular pathogenesis of lung cancer. J Thorac Cardiovasc Surg 118:1136–52.PubMedGoogle Scholar
  44. 44.
    Suda Y, Aizawa S, Hirai S, Inoue T, Furuta Y, Suzuki M, Hirohashi S, Ikawa Y (1987) Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice. EMBO J 6: 4055–65.PubMedGoogle Scholar
  45. 45.
    Sandmoller A, Halter R, Suske G, Paul D, Beato M (1995) A transgenic mouse model for lung adenocarcinoma. Cell Growth Differ 6: 97–103.PubMedGoogle Scholar
  46. 46.
    Zhao B, Magdaleno S, Chua S et al. (2000) Transgenic mouse models for lung cancer. Exp. Lung Res 26: 567–79.CrossRefGoogle Scholar
  47. 47.
    Macleod KF, Jacks T (1999) Insights into cancer from transgenic mouse models. J Pathol 187: 43–60.PubMedCrossRefGoogle Scholar
  48. 48.
    DeMayo FJ, Tsai SY (2001) Targeted gene regulation and gene ablation. Trends Endocrinol Metab 12: 348–53.PubMedCrossRefGoogle Scholar
  49. 49.
    Lewandoski M (2001) Conditional control of gene expression in the mouse. Nat Rev Genet 2: 743–55.PubMedCrossRefGoogle Scholar
  50. 50.
    Shockett PE, Schatz DG (1996) Diverse strategies for tetracycline-regulated inducible gene expression. Proc Natl Acad Sci USA 93: 5173–6.PubMedCrossRefGoogle Scholar
  51. 51.
    Fisher GH, Wellen SL, Klimstra D et al. (2001) Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev 15: 3249–62.PubMedCrossRefGoogle Scholar
  52. 52.
    Meuwissen R, Linn SC, van der Valk M, Mooi WJ, Berns A (2001) Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene. Oncogene 20: 6551–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Meuwissen R, Linn SC, Linnoila RI, Zevenhoven J, Mooi WJ, Berns A (2003) Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 4: 181–9.PubMedCrossRefGoogle Scholar
  54. 54.
    Kim CF, Jackson EL, Kirsch DG, et al. (2005) Mouse models of human non-small-cell lung cancer: raising the bar. Cold Spring Harb Symp Quant Biol 70:241–50.PubMedCrossRefGoogle Scholar
  55. 55.
    DeMayo FJ, Finegold MJ, Hansen TN et al. (1991) Expression of SV40 T antigen under control of rabbit uteroglobin promoter in transgenic mice. Am J Physiol 261: L70–6.Google Scholar
  56. 56.
    Wikenheiser KA, Clark JC, Linnoila RI et al. (1992) Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res 52:5342–52.Google Scholar
  57. 57.
    Chailley-Heu B, Rambaud C, Barlier-Mur AM et al. (2001) A model of pulmonary adenocarcinoma in transgenic mice expressing the simian virus 40 T antigen driven by the rat Calbindin-D9K (CaBP9K) promoter. J Pathol 195:482–9.Google Scholar
  58. 58.
    Ehrhardt A, Bartels T, Geick A et al. (2001) Development of pulmonary bronchiolo-alveolar adenocarcinomas in transgenic mice overexpressing murine c-myc and epidermal growth factor in alveolar type II pneumocytes. Br J Cancer 84:813–8.Google Scholar
  59. 59.
    Kerkhoff E, Fedorov LM, Siefken R et al. (2000) Lung-targeted expression of the c-Raf-1 kinase in transgenic mice exposes a novel oncogenic character of the wild-type protein. Cell Growth Differ 11:185–90.Google Scholar
  60. 60.
    Sunday ME, Haley KJ, Sikorski K et al. (1999) Calcitonin driven v-Ha-ras induces multilineage pulmonary epithelial hyperplasias and neoplasms. Oncogene 18:4336–47.Google Scholar
  61. 61.
    Chen YQ, Zhou YQ, Fu LH et al. (2002) Multiple pulmonary adenomas in the lung of transgenic mice overexpressing the RON receptor tyrosine kinase. Recepteur d’origine nantais. Carcinogenesis 23:1811–9.Google Scholar
  62. 62.
    Linnoila RI, Sahu A, Miki M et al. (2000) Morphometric analysis of CC10-hASH1 transgenic mouse lung: a model for bronchiolization of alveoli and neuroendocrine carcinoma. Exp Lung Res 26:595–615.Google Scholar
  63. 63.
    Sharkey FE, Fogh J, Hajdu S et al. (1978) Experience in surgical pathology with human tumor growth in the nude mouse. In: Fogh J, Giovanella B, The nude mouse in experimental and clinical research. Academic Press, New York, p. 188.Google Scholar
  64. 64.
    Boven E, Winograd B, Berger DP, et al. (1992) Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study. Cancer Res 52: 5940–7.PubMedGoogle Scholar
  65. 65.
    Takimoto CH (2001) Why drugs fail: of mice and men revisited. Clin Cancer Res 7: 229–30.PubMedGoogle Scholar
  66. 66.
    Fodstad O (1988) Representativity of xenografts for clinical cancer. Tumor and host characteristics as variables of tumor take rate. In Winograd B, Peckham MJ, Pinedo HM (eds.), Human Tumor Xenografts in Anticancer Drug Development. Springer-Verlag, Berlin, pp. 15–21.Google Scholar
  67. 67.
    Fidler IJ (1986) Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Rev 5: 29–49.PubMedCrossRefGoogle Scholar
  68. 68.
    Fidler IJ (1991) Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis. Cancer Metastasis Rev 10: 229–43.PubMedCrossRefGoogle Scholar
  69. 69.
    Kerbel RS, Cornil I, Theodorescu D (1991) Importance of orthotopic transplantation procedures in assessing the effects of transfected genes on human tumor growth and metastasis. Cancer Metastasis Rev 10: 201–15.PubMedCrossRefGoogle Scholar
  70. 70.
    Paget S (1889) Secondary growths of cancer of breast. Lancet 1: 571–3.CrossRefGoogle Scholar
  71. 71.
    Howard RB, Chu H, Zeligman BE (1991). Irradiated nude rat model for orthotopic human lung cancers. Cancer Res 51: 3274–80.PubMedGoogle Scholar
  72. 72.
    Howard RB, Mullen JB, Pagura ME, Johnston MR (1999) Characterization of a highly metastatic, orthotopic lung cancer model in the nude rat. Clin Exp Metastasis 17: 157–62.PubMedCrossRefGoogle Scholar
  73. 73.
    McLemore TL, Liu MC, Blacker PC et al. (1987) Novel intrapulmonary model for orthotopic propagation of human lung cancers in athymic nude mice. Cancer Res 47: 5132–40.PubMedGoogle Scholar
  74. 74.
    Wang X., Fu X, Hoffman RM (1992) A new patient-like metastatic model of human lung cancer constructed orthotopically with intact tissue via thoracotomy in immunodeficient mice. Int J Cancer 51: 992–5.PubMedCrossRefGoogle Scholar
  75. 75.
    Rashidi B, Yang M, Jiang P (2000) A highly metastatic Lewis lung carcinoma orthotopic green fluorescent protein model. Clin Exp Metastasis 18: 57–60.PubMedCrossRefGoogle Scholar
  76. 76.
    McLemore TL, Eggleston JC, Shoemaker RH et al. (1988) Comparison of intrapulmonary, percutaneous intrathoracic, and subcutaneous models for the propagation of human pulmonary and nonpulmonary cancer cell lines in athymic nude mice. Cancer Res 48: 2880–6.PubMedGoogle Scholar
  77. 77.
    Kuo TH, Kubota T, Watanabe M et al. (1992) Orthotopic reconstitution of human small-cell lung carcinoma after intravenous transplantation in SCID mice. Anticancer Res 12: 1407–10.PubMedGoogle Scholar
  78. 78.
    Kuo TH, Kubota T, Watanabe M. (1993) Site-specific chemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcutaneously in SCID mice: the importance of orthotopic models to obtain relevant drug evaluation data. Anticancer Res 13: 627–30.PubMedGoogle Scholar
  79. 79.
    Nagamachi Y, Tani M, Shimizu K, Tsuda H, Niitsu Y, Yokota J (1998) Orthotopic growth and metastasis of human non-small cell lung carcinoma cell injected into the pleural cavity of nude mice. Cancer Lett 127: 203–9.PubMedCrossRefGoogle Scholar
  80. 80.
    Miyoshi T, Kondo K, Ishikura H, Kinoshita H, Matsumori Y, Monden Y (2000) SCID Mouse Lymphogenous Metastatic Model of Human Lung Cancer Constructed Using Orthotopic Inoculation of Cancer Cells. Anticancer Res 20: 161–4.PubMedGoogle Scholar
  81. 81.
    Cuenca RE, Takita H, Bankert R (1996) Orthotopic engraftment of human lung tumours in SCID mice for the study of metastasis. Surg Oncol 5: 85–91.PubMedCrossRefGoogle Scholar
  82. 82.
    Van Weerden WM, Romijn JC (2000) Use of nude mouse xenograft models in prostate cancer research. Prostate 43: 263–71.PubMedCrossRefGoogle Scholar
  83. 83.
    Wang X, Fu X, Kubota T, Hoffman RM (1992) A new patient-like metastatic model of human small-cell lung cancer constructed orthotopically with intact tissue via thoracotomy in nude mice. Anticancer Res 12: 1403–6.PubMedGoogle Scholar
  84. 84.
    Vertrees RA, Deyo DJ, Quast M et al. (2000) Development of a human to murine orthotopic xenotransplanted lung cancer model. J Invest Surg 13:349–58.Google Scholar
  85. 85.
    Glaves D (1986) Detection of circulating metastatic cells. Prog Clin Biol Res 212: 151–67.PubMedGoogle Scholar
  86. 86.
    Yang M, Hasegawa S, Jiang P et al. (1998) Widespread skeletal metastatic potential of human lung cancer revealed by green fluorescent protein expression. Cancer Res 58: 4217–21.PubMedGoogle Scholar
  87. 87.
    Clark EA, Golub TR, Lander ES, Hynes RO (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406: 532–5.PubMedCrossRefGoogle Scholar
  88. 88.
    Fidler IJ, Poste G (1985) The cellular heterogeneity of malignant neoplasms: implications for adjuvant chemotherapy. Semin Oncol 12: 207–21.PubMedGoogle Scholar
  89. 89.
    Fidler IJ (2002) The organ microenvironment and cancer metastasis. Differentiation 70: 498–505.PubMedCrossRefGoogle Scholar
  90. 90.
    Carmichael J and Smyth JF (1988) Chemotherapy studies in human non-small cell lung cancer xenografts transplanted in immune-deprived mice. In: Winograd B, Peckham MJ, Pinedo HM (eds.), Human Tumour Xenografts in Anticancer Drug Development, Springer, New York, pp. 51–56.Google Scholar
  91. 91.
    Dinney CP, Fishbeck R, Singh RK et al. (1995) Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. J Urol 154: 1532–8.PubMedCrossRefGoogle Scholar
  92. 92.
    Chu LW, Pettaway CA, Liang JC (2001) Genetic abnormalities specifically associated with varying metastatic potential of prostate cancer cell lines as detected by comparative genomic hybridization. Cancer Genet Cytogenet 127: 161–7.PubMedCrossRefGoogle Scholar
  93. 93.
    Liu J, Blackhall F, Seiden-Long I et al. (2004) Modeling of lung cancer by an orthotopically growing H460SM variant cell line reveals novel candidate genes for systemic metastasis. Oncogene 23: 6316–24.PubMedCrossRefGoogle Scholar
  94. 94.
    Kozaki K, Miyaishi O, Tsukamoto T, Tatematsu Y, Hida T, Takahashi T, Takahashi T (2000) Establishment and characterization of a human lung cancer cell line NCI- H460-LNM35 with consistent lymphogenous metastasis via both subcutaneous and orthotopic propagation. Cancer Res 60: 2535–40.PubMedGoogle Scholar
  95. 95.
    Khleif SN, Curt GA (1997) Animal models in drug development. In: Holland JF, Bast RC, Morton DL, Weichselbaum RR (eds.), Cancer Medicine. Williams & Wilkins, Baltimore, pp. 855–68.Google Scholar
  96. 96.
    Shoemaker RH, McLemore TL, Abbott BJ et al. (1988) Human tumor xenograft models for use with an in vitro-based, disease-oriented antitumor drug screening program. In: Winograd B, Peckham MJ, Pinedo HM (eds), Human Tumor xenografts in Anticancer Drug Development. Springer-Verlag, Berlin, pp. 115–20.Google Scholar
  97. 97.
    Mulvin DW, Howard RB, Mitchell DH et al. (1992) Secondary screening system for preclinical testing of human lung cancer therapies. J Natl Cancer Inst 84: 31–7.PubMedCrossRefGoogle Scholar
  98. 98.
    Van Dyke T, Jacks T (2002) Cancer modeling in the modern era: progress and challenges. Cell 108: 135–44.PubMedCrossRefGoogle Scholar
  99. 99.
    Zeligman BE, Howard RB, Marcell T, Chu H, Rossi RP, Mulvin D, Johnston MR (1992) Chest roentgenographic techniques for demonstrating human lung tumour xenografts in nude rats. Lab Anim 26: 100–106.PubMedCrossRefGoogle Scholar
  100. 100.
    Johnston MR, Mullen JB, Pagura M, Howard RB (2001) Validation of an orthotopic model of human lung cancer with regional and systemic metastases. Ann Thorac Surg 71: 1120–5.PubMedCrossRefGoogle Scholar
  101. 101.
    Kraus-Berthier L, Jan M, Guilbaud N, Naze M, Pierre A, Atassi G (2002) Histology and sensitivity to anticancer drugs of two human non-small lung cell lung carcinomas implanted in the pleural cavity of nude mice. Clin Cancer Res 6: 297–304.Google Scholar
  102. 102.
    Wilmanns C, Fan D, O‘Brian CA, Bucana CD, Fidler IJ (1992) Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5- fluorouracil. Int J Cancer 52: 98–104.PubMedCrossRefGoogle Scholar
  103. 103.
    Davies B, Brown PD, East N, Crimmin MJ, Balkwill FR (1993) A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 53: 2087–91.PubMedGoogle Scholar
  104. 104.
    Marincola FM, Da Pozzo LF, Drucker BJ, Holder WD (1990) Adoptive immunotherapy of human pancreatic cancer with lymphokine- activated killer cells and interleukin-2 in a nude mouse model. Surgery 108: 919–29.PubMedGoogle Scholar
  105. 105.
    Russell PJ, Ho SI, Boniface GR, Izard ME, Philips J, Raghavan D, Walker KZ (1991) Growth and metastasis of human bladder cancer xenografts in the bladder of nude rats. A model for intravesical radioimmunotherapy. Urol Res 19: 207–13.PubMedCrossRefGoogle Scholar
  106. 106.
    Schuster JM, Friedman HS, Archer GE, Fuchs HE, McLendon RE, Colvin OM, Bigner DD (1993) Intraarterial therapy of human glioma xenografts in athymic rats using 4-hydroperoxycyclophosphamide. Cancer Res 53: 2338–43.PubMedGoogle Scholar
  107. 107.
    Liu J, Tsao MS, Pagura M, Shalinsky DR, Khoka R, Fata J, Johnston MR (2003) Early combined treatment with carboplatin and the MMP inhibitor prolongs survival and reduces systemic metastasis in an aggressive orthotopic lung cancer model. Lung Cancer 42:335–44.PubMedCrossRefGoogle Scholar
  108. 108.
    Liu J, Costello PC, Pham N, Pintillie M, Jabali M, Sanghera J, Tsao MS, Johnston MR (2006) Integrin linked kinase (ILK) inhibitor KP-392 inhibits tumor growth and metastasis in an orthotopic human non small lung cancer model. J Thorac Oncol 1:771–9.PubMedCrossRefGoogle Scholar
  109. 109.
    Pasqualini R, Ruoslahti E (1996) Organ targeting in vivo using phage display peptide libraries. Nature 380: 364–6.PubMedCrossRefGoogle Scholar
  110. 110.
    Price JE (1994) Analyzing the metastatic phenotype. J Cell Biochem 56: 16–22.PubMedCrossRefGoogle Scholar
  111. 111.
    97. Wistuba II, Bryant D, Behrens C, Milchgrub S, Virmani AK, Ashfaq R, Minna JD, Gazdar AF (1999) Comparison of features of human lung cancer cell lines and their corresponding tumors. Clin Cancer Res 5: 991–1000.PubMedGoogle Scholar
  112. 112.
    Winton T, Livingston R, Johnson D et al. (2005) Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352:2589–97.PubMedCrossRefGoogle Scholar
  113. 113.
    Liu J, Li M, Tsao MS, Johnston MR (2003) An experimental lung cancer model for the assessment of adjuvant therapies following surgical resection. Proc Am Assoc Cancer Res Toronto, Canada.Google Scholar
  114. 114.
    Liu J, Wong H, Moselhy J, Bowen B, Wu XY, Johnston MR (2006) Targeting colloidal particulates to thoracic lymph nodes. Lung Cancer 51:377–86.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Division of Applied Molecular Oncology, Princess Margaret HospitalUniversity Health NetworkTorontoCanada
  2. 2.Division of Thoracic Surgery, Department of SurgeryDalhousie UniversityHalifaxCanada

Personalised recommendations